IBDEI0CD ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15669,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff right nondom side
 ;;^UTILITY(U,$J,358.3,15669,1,4,0)
 ;;=4^I69.843
 ;;^UTILITY(U,$J,358.3,15669,2)
 ;;=^5007533
 ;;^UTILITY(U,$J,358.3,15670,0)
 ;;=I69.844^^47^703^71
 ;;^UTILITY(U,$J,358.3,15670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15670,1,3,0)
 ;;=3^Monoplg low lmb fol oth cerebvasc dis aff left nondom side
 ;;^UTILITY(U,$J,358.3,15670,1,4,0)
 ;;=4^I69.844
 ;;^UTILITY(U,$J,358.3,15670,2)
 ;;=^5133578
 ;;^UTILITY(U,$J,358.3,15671,0)
 ;;=I69.241^^47^703^74
 ;;^UTILITY(U,$J,358.3,15671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15671,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff right dom side
 ;;^UTILITY(U,$J,358.3,15671,1,4,0)
 ;;=4^I69.241
 ;;^UTILITY(U,$J,358.3,15671,2)
 ;;=^5007469
 ;;^UTILITY(U,$J,358.3,15672,0)
 ;;=I69.242^^47^703^75
 ;;^UTILITY(U,$J,358.3,15672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15672,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff left dom side
 ;;^UTILITY(U,$J,358.3,15672,1,4,0)
 ;;=4^I69.242
 ;;^UTILITY(U,$J,358.3,15672,2)
 ;;=^5133574
 ;;^UTILITY(U,$J,358.3,15673,0)
 ;;=I69.243^^47^703^76
 ;;^UTILITY(U,$J,358.3,15673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15673,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff r nondom side
 ;;^UTILITY(U,$J,358.3,15673,1,4,0)
 ;;=4^I69.243
 ;;^UTILITY(U,$J,358.3,15673,2)
 ;;=^5007470
 ;;^UTILITY(U,$J,358.3,15674,0)
 ;;=I69.244^^47^703^77
 ;;^UTILITY(U,$J,358.3,15674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15674,1,3,0)
 ;;=3^Monoplg low lmb fol oth ntrm intcrn hemor aff l nondom side
 ;;^UTILITY(U,$J,358.3,15674,1,4,0)
 ;;=4^I69.244
 ;;^UTILITY(U,$J,358.3,15674,2)
 ;;=^5007471
 ;;^UTILITY(U,$J,358.3,15675,0)
 ;;=G35.^^47^703^78
 ;;^UTILITY(U,$J,358.3,15675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15675,1,3,0)
 ;;=3^Multiple sclerosis
 ;;^UTILITY(U,$J,358.3,15675,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,15675,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,15676,0)
 ;;=G20.^^47^703^79
 ;;^UTILITY(U,$J,358.3,15676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15676,1,3,0)
 ;;=3^Parkinson's disease
 ;;^UTILITY(U,$J,358.3,15676,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,15676,2)
 ;;=^5003770
 ;;^UTILITY(U,$J,358.3,15677,0)
 ;;=G21.4^^47^703^80
 ;;^UTILITY(U,$J,358.3,15677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15677,1,3,0)
 ;;=3^Vascular parkinsonism
 ;;^UTILITY(U,$J,358.3,15677,1,4,0)
 ;;=4^G21.4
 ;;^UTILITY(U,$J,358.3,15677,2)
 ;;=^5003776
 ;;^UTILITY(U,$J,358.3,15678,0)
 ;;=I69.051^^47^703^48
 ;;^UTILITY(U,$J,358.3,15678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15678,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff right dominant side
 ;;^UTILITY(U,$J,358.3,15678,1,4,0)
 ;;=4^I69.051
 ;;^UTILITY(U,$J,358.3,15678,2)
 ;;=^5007409
 ;;^UTILITY(U,$J,358.3,15679,0)
 ;;=I69.052^^47^703^46
 ;;^UTILITY(U,$J,358.3,15679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15679,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff left dominant side
 ;;^UTILITY(U,$J,358.3,15679,1,4,0)
 ;;=4^I69.052
 ;;^UTILITY(U,$J,358.3,15679,2)
 ;;=^5007410
 ;;^UTILITY(U,$J,358.3,15680,0)
 ;;=I69.053^^47^703^49
 ;;^UTILITY(U,$J,358.3,15680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15680,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff right nondom side
 ;;^UTILITY(U,$J,358.3,15680,1,4,0)
 ;;=4^I69.053
 ;;^UTILITY(U,$J,358.3,15680,2)
 ;;=^5007411
 ;;^UTILITY(U,$J,358.3,15681,0)
 ;;=I69.054^^47^703^47
 ;;^UTILITY(U,$J,358.3,15681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15681,1,3,0)
 ;;=3^Hemiplga fol ntrm subarach hemor aff left nondom side
 ;;^UTILITY(U,$J,358.3,15681,1,4,0)
 ;;=4^I69.054
 ;;^UTILITY(U,$J,358.3,15681,2)
 ;;=^5007412
 ;;^UTILITY(U,$J,358.3,15682,0)
 ;;=I50.41^^47^704^1
 ;;^UTILITY(U,$J,358.3,15682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15682,1,3,0)
 ;;=3^Acute combined systolic and diastolic (congestive) hrt fail
 ;;^UTILITY(U,$J,358.3,15682,1,4,0)
 ;;=4^I50.41
 ;;^UTILITY(U,$J,358.3,15682,2)
 ;;=^5007248
 ;;^UTILITY(U,$J,358.3,15683,0)
 ;;=I50.31^^47^704^2
 ;;^UTILITY(U,$J,358.3,15683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15683,1,3,0)
 ;;=3^Acute diastolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15683,1,4,0)
 ;;=4^I50.31
 ;;^UTILITY(U,$J,358.3,15683,2)
 ;;=^5007244
 ;;^UTILITY(U,$J,358.3,15684,0)
 ;;=I50.43^^47^704^3
 ;;^UTILITY(U,$J,358.3,15684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15684,1,3,0)
 ;;=3^Acute on chronic combined systolic and diastolic hrt fail
 ;;^UTILITY(U,$J,358.3,15684,1,4,0)
 ;;=4^I50.43
 ;;^UTILITY(U,$J,358.3,15684,2)
 ;;=^5007250
 ;;^UTILITY(U,$J,358.3,15685,0)
 ;;=I50.33^^47^704^4
 ;;^UTILITY(U,$J,358.3,15685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15685,1,3,0)
 ;;=3^Acute on chronic diastolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15685,1,4,0)
 ;;=4^I50.33
 ;;^UTILITY(U,$J,358.3,15685,2)
 ;;=^5007246
 ;;^UTILITY(U,$J,358.3,15686,0)
 ;;=I50.23^^47^704^5
 ;;^UTILITY(U,$J,358.3,15686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15686,1,3,0)
 ;;=3^Acute on chronic systolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15686,1,4,0)
 ;;=4^I50.23
 ;;^UTILITY(U,$J,358.3,15686,2)
 ;;=^5007242
 ;;^UTILITY(U,$J,358.3,15687,0)
 ;;=I50.21^^47^704^6
 ;;^UTILITY(U,$J,358.3,15687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15687,1,3,0)
 ;;=3^Acute systolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15687,1,4,0)
 ;;=4^I50.21
 ;;^UTILITY(U,$J,358.3,15687,2)
 ;;=^5007240
 ;;^UTILITY(U,$J,358.3,15688,0)
 ;;=I25.111^^47^704^7
 ;;^UTILITY(U,$J,358.3,15688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15688,1,3,0)
 ;;=3^Athscl hrt disease of native cor art w ang pctrs w spasm
 ;;^UTILITY(U,$J,358.3,15688,1,4,0)
 ;;=4^I25.111
 ;;^UTILITY(U,$J,358.3,15688,2)
 ;;=^5007109
 ;;^UTILITY(U,$J,358.3,15689,0)
 ;;=I25.118^^47^704^8
 ;;^UTILITY(U,$J,358.3,15689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15689,1,3,0)
 ;;=3^Athscl hrt disease of native cor art w oth ang pctrs
 ;;^UTILITY(U,$J,358.3,15689,1,4,0)
 ;;=4^I25.118
 ;;^UTILITY(U,$J,358.3,15689,2)
 ;;=^5007110
 ;;^UTILITY(U,$J,358.3,15690,0)
 ;;=I25.119^^47^704^9
 ;;^UTILITY(U,$J,358.3,15690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15690,1,3,0)
 ;;=3^Athscl hrt disease of native cor art w unsp ang pctrs
 ;;^UTILITY(U,$J,358.3,15690,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,15690,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,15691,0)
 ;;=I25.110^^47^704^10
 ;;^UTILITY(U,$J,358.3,15691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15691,1,3,0)
 ;;=3^Athscl hrt disease of native cor art w unstable ang pctrs
 ;;^UTILITY(U,$J,358.3,15691,1,4,0)
 ;;=4^I25.110
 ;;^UTILITY(U,$J,358.3,15691,2)
 ;;=^5007108
 ;;^UTILITY(U,$J,358.3,15692,0)
 ;;=I25.10^^47^704^11
 ;;^UTILITY(U,$J,358.3,15692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15692,1,3,0)
 ;;=3^Athscl hrt disease of native cor art w/o ang pctrs
 ;;^UTILITY(U,$J,358.3,15692,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,15692,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,15693,0)
 ;;=I48.0^^47^704^28
 ;;^UTILITY(U,$J,358.3,15693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15693,1,3,0)
 ;;=3^Paroxysmal atrial fibrillation
 ;;^UTILITY(U,$J,358.3,15693,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,15693,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,15694,0)
 ;;=I42.9^^47^704^13
 ;;^UTILITY(U,$J,358.3,15694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15694,1,3,0)
 ;;=3^Cardiomyopathy, unspecified
 ;;^UTILITY(U,$J,358.3,15694,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,15694,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,15695,0)
 ;;=I50.42^^47^704^14
 ;;^UTILITY(U,$J,358.3,15695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15695,1,3,0)
 ;;=3^Chronic combined systolic and diastolic hrt fail
 ;;^UTILITY(U,$J,358.3,15695,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,15695,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,15696,0)
 ;;=I50.32^^47^704^15
 ;;^UTILITY(U,$J,358.3,15696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15696,1,3,0)
 ;;=3^Chronic diastolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15696,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,15696,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,15697,0)
 ;;=J44.1^^47^704^16
 ;;^UTILITY(U,$J,358.3,15697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15697,1,3,0)
 ;;=3^Chronic obstructive pulmonary disease w (acute) exacerbation
 ;;^UTILITY(U,$J,358.3,15697,1,4,0)
 ;;=4^J44.1
 ;;^UTILITY(U,$J,358.3,15697,2)
 ;;=^5008240
 ;;^UTILITY(U,$J,358.3,15698,0)
 ;;=J44.9^^47^704^17
 ;;^UTILITY(U,$J,358.3,15698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15698,1,3,0)
 ;;=3^Chronic obstructive pulmonary disease, unspecified
 ;;^UTILITY(U,$J,358.3,15698,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,15698,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,15699,0)
 ;;=I50.22^^47^704^18
 ;;^UTILITY(U,$J,358.3,15699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15699,1,3,0)
 ;;=3^Chronic systolic (congestive) heart failure
 ;;^UTILITY(U,$J,358.3,15699,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,15699,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,15700,0)
 ;;=Z98.61^^47^704^20
 ;;^UTILITY(U,$J,358.3,15700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15700,1,3,0)
 ;;=3^Coronary angioplasty status
 ;;^UTILITY(U,$J,358.3,15700,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,15700,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,15701,0)
 ;;=I42.0^^47^704^22
 ;;^UTILITY(U,$J,358.3,15701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15701,1,3,0)
 ;;=3^Dilated cardiomyopathy
 ;;^UTILITY(U,$J,358.3,15701,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,15701,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,15702,0)
 ;;=J43.9^^47^704^23
 ;;^UTILITY(U,$J,358.3,15702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15702,1,3,0)
 ;;=3^Emphysema, unspecified
 ;;^UTILITY(U,$J,358.3,15702,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,15702,2)
 ;;=^5008238
